Patient adherence

Advertisement

cGxPJobs Banner

Bio-Pharma Pharma

Lilly’s Oral GLP-1 Orforglipron Delivers Strong Phase 3 Results in Type 2 Diabetes

INDIANAPOLIS, Oct. 15, 2025 — Eli Lilly and Company (NYSE: LLY) announced positive topline results from two pivotal Phase...

By cGxPwire Editor
October 15, 2025

Read More

Lupin Wins U.S. FDA Approval for First Nanomi LAI Injectable

September 3, 2025 – Mumbai & Naples – Lupin Limited announced U.S. FDA approval for its Risperidone extended-release injectable...

By cGxPwire Editor
September 10, 2025

Read More

Advertisement

cGxPJobs

Directory